Structural Biology in Drug Discovery

 Rational drug design aims to develop small molecules (drugs) with a therapeutic effect by targeting biomolecules in order to influence their biological function. Structural biology has a diverse arsenal of methods available to study (bio) molecular structures. Information on the shape and possible interaction sites of binding sites on these molecules can be used to design small molecules with high binding affinity. The structural information is a valuable input in different stages of drug development such as lead optimization or drug design. Important starting point in rational drug design is that Structural determination of bio molecules could help as therapeutic target. Soon after knowing the structure of biological target, an impending binding site for drugs and its interactions have to be identified in the period of drug design

 

  • 8-1. Cancer drug design and discovery
  • 8-2. Molecular modeling in drug design
  • 8-3. Transformative concepts for drug design
  • 8-4. Molecular basis of drug design
  • 8-5. Frontiers in drug design and drug discovery
  • 8-6. Protein crystallography in drug discovery
  • 8-7. Fragment based drug design
  • 8-8. Drug design strategies

Related Conference of Structural Biology in Drug Discovery

April 16-17, 2026

19th World Congress on Stem Cell Research

Tokyo, Japan
June 08-09, 2026

9th Global Conference on Cell and Gene Therapy

Rome, Italy
June 15-16, 2026

22nd Global Summit on Stem Cell & Regenerative Medicine

Amsterdam, Netherlands
June 15-16, 2026

13th World Congress on Epigenetics and Chromosome

Paris, France
June 18-19, 2026

19th International Conference on Genomics & Pharmacogenomics

Singapore City, Singapore
September 25-26, 2025

6th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada

Structural Biology in Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in